血液系统恶性肿瘤的临床试验
总计15541个结果
-
Tel-Aviv Sourasky Medical CenterMeir Medical Center; Max Planck Institute for Infection Biology未知
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine完全的
-
Centre Hospitalier Universitaire de Besancon终止
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Kite, A Gilead Company邀请报名
-
CASI Pharmaceuticals, Inc.完全的
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.可用的
-
Shandong UniversityJuventas Cell Therapy Ltd.未知
-
AstraZenecaParexel主动,不招人
-
Medical College of Wisconsin完全的Malignancies, Hematologic美国
-
University of California, Davis完全的
-
Minsk Scientific-Practical Center for Surgery,...Belarusian State Medical University完全的
-
Senti Biosciences尚未招聘反洗钱/材料数据表 | CD33 表达血液恶性肿瘤 | FLT3 表达血液恶性肿瘤
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine撤销淋巴血液系统恶性肿瘤 | 脐带血移植
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la Loire完全的
-
Institut Paoli-CalmettesSanofi尚未招聘
-
The Affiliated People's Hospital of Ningbo University招聘中
-
Sanofi完全的血液系统恶性肿瘤希腊, 西班牙, 秘鲁, 以色列, 美国, 阿根廷, 比利时, 巴西, 智利, 芬兰, 法国, 意大利, 墨西哥, 俄罗斯联邦, 火鸡, 乌克兰, 英国
-
University of CopenhagenZealand University Hospital邀请报名
-
University Hospital TuebingenLudwig-Maximilians - University of Munich; University Hospital Augsburg完全的Relapse of Hematological Malignancies
-
M.D. Anderson Cancer Center招聘中
-
University Hospital, Strasbourg, France未知
-
Universitaire Ziekenhuizen KU LeuvenInstitutul Clinic Fundeni完全的
-
Chroma Therapeutics完全的
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的
-
The Affiliated People's Hospital of Ningbo UniversityUTC Therapeutics Inc.招聘中
-
Antengene Therapeutics LimitedBristol-Myers Squibb招聘中